Literature DB >> 21398580

The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib.

Sascha Meyer dos Santos1, Ute Klinkhardt, Klaus Scholich, Karen Nelson, Nadejda Monsefi, Hans Deckmyn, Karina Kuczka, Anita Zorn, Sebastian Harder.   

Abstract

The membrane-anchored CX3C chemokine fractalkine (FKN) is expressed on activated endothelium and is associated with the development of atherosclerosis. The potential of FKN in mediating platelet adhesion beyond platelet activation remains unexplored to date. A flow-based adhesion assay was used to study the adhesion of platelets to immobilized FKN under physiologic flow conditions. Platelet adhesion to von Willebrand factor (VWF) was increased in the presence of FKN at 600 inverse seconds. Additional platelet adhesion to FKN coimmobilized with VWF was dependent on the FKN receptor CX3CR1 and activation of glycoprotein (GP) IIb/IIIa. The number of platelets rolling on VWF was likewise enhanced in the presence of FKN. The enhancement of rolling on FKN and VWF was insensitive to anti-CX3CR1 antibody but was fully inhibited by neutralizing GPIbα function. The extracellular domain of GPIbα was covalently coupled to fluorescent microspheres, and microsphere binding was significantly higher in the presence of FKN. Platelet adhesion to activated endothelium in vitro and to intact human arteries was substantially increased in an FKN-dependent manner. These data demonstrate that endothelial expressed FKN activates platelets via its cognate receptor CX3CR1, whereas platelet adhesion is predominantly mediated by GPIbα and independent of CX3CR1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398580     DOI: 10.1182/blood-2011-02-335471

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants.

Authors:  Sascha Meyer Dos Santos; Anita Zorn; Zeno Guttenberg; Bettina Picard-Willems; Christina Kläffling; Karen Nelson; Ute Klinkhardt; Sebastian Harder
Journal:  Biomicrofluidics       Date:  2013-10-04       Impact factor: 2.800

Review 2.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

3.  Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.

Authors:  Prakash Doddapattar; Nirav Dhanesha; Mehul R Chorawala; Chandler Tinsman; Manish Jain; Manasa K Nayak; Janice M Staber; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-18       Impact factor: 8.311

4.  CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice.

Authors:  Matthew Riopel; Melanie Vassallo; Erik Ehinger; Jennifer Pattison; Karen Bowden; Holger Winkels; Maria Wilson; Ron de Jong; Sanjay Patel; Deepika Balakrishna; James Bilakovics; Andrea Fanjul; Artur Plonowski; Christopher J Larson; Klaus Ley; Pedro Cabrales; Joseph L Witztum; Jerrold M Olefsky; Yun Sok Lee
Journal:  Mol Metab       Date:  2018-12-02       Impact factor: 7.422

Review 5.  Depression and Cardiovascular Disease: The Viewpoint of Platelets.

Authors:  Patrizia Amadio; Marta Zarà; Leonardo Sandrini; Alessandro Ieraci; Silvia Stella Barbieri
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

Review 6.  Rickettsia-Host-Tick Interactions: Knowledge Advances and Gaps.

Authors:  Hwan Keun Kim
Journal:  Infect Immun       Date:  2022-08-22       Impact factor: 3.609

7.  Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis.

Authors:  Shuo Miao; Meng Lu; Yue Liu; Dan Shu; Ying Zhu; Wei Song; Yuanyuan Ma; Rong Ma; Bixiang Zhang; Chao Fang; Zhang-Yin Ming
Journal:  Mol Oncol       Date:  2020-09-02       Impact factor: 6.603

8.  Physical exercise is associated with a reduction in plasma levels of fractalkine, TGF-β1, eotaxin-1 and IL-6 in younger adults with mobility disability.

Authors:  Parvin Kumar; Miranda Stiernborg; Anna Fogdell-Hahn; Kristoffer Månsson; Tomas Furmark; Daniel Berglind; Philippe A Melas; Yvonne Forsell; Catharina Lavebratt
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.